[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Spectrocor\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":42},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":27,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100522551","spectroscopic-assessment-of-intramyocardial-oxygen-saturation-during-open-heart-surgery-100522551",false,"NCT06084091","Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery","ECS","Inclusion Criteria:\n\n* Any 18 to 90-year-old patient scheduled for an open-heart operation\n* The ability to understand the study's objective and the risks involved.\n* Informed consent obtained, including the agreement to authorization to use the protected personal patient records according to privacy legislation.\n\nExclusion Criteria:\n\n* Inability to obtain an informed consent form\n* Patients included as vulnerable population according to Finnish Medical Research Act, including retarded, pregnant women, nursing mothers, prisoners, or forensic patients.","ALL","18 Years","90 Years",{"count":20,"type":21},40,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to test in the safety and performance of intraoperative myocardial spectroscopic measurement in open-heart surgery patients\n\nThe main questions it aims to answer are:\n\n* The Devices can record myocardial spectrometric data for analysis, and\n* How these measures correlate with the occurring events, procedures, and clinical parameters during the operation.\n* Number of participants with device-related adverse events as assessed by CTCAE v4.0",[25,26],"Coronary Artery Disease","Heart Valve Diseases",[28,29],"monitoring, intraoperative","Heart Surgery","RECRUITING","2026-08-20",{"date":33,"type":34},"2026-08-21","ACTUAL",{"date":36,"type":34},"2023-10-06",{"date":38,"type":21},"2026-12-31",{"name":40,"class":41},"Spectrocor","INDUSTRY",""]